Publications:

---

Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.

Cancer Medicine

Sun, Shengjie S; Du, Wenjuan W; Sun, Qiong Q; Zhao, Xiao X; Qin, Boyu B; Shi, Duozhi D; Wan, Chong C; Wu, Zhiyong Z

Publication Date: 2021-10

Variant appearance in text: EGFR: Gly719Asn

PubMed Link: 34599863

Variant Present in the following documents:

• CAM4-10-7360-s002.xlsx, sheet 2

View BVdb publication page

---

Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.

Cancer Medicine

Sun, Shengjie S; Du, Wenjuan W; Sun, Qiong Q; Zhao, Xiao X; Qin, Boyu B; Shi, Duozhi D; Wan, Chong C; Wu, Zhiyong Z

Publication Date: 2021-10

Variant appearance in text: EGFR: Gly719Asn

PubMed Link: 34599863

Variant Present in the following documents:

• CAM4-10-7360-s002.xlsx, sheet 2

View BVdb publication page

---

Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.

Bmc Cancer

Araujo, Luiz Henrique LH; Souza, Bianca Mendes BM; Leite, Laura Rabelo LR; Parma, Sabrina A F SAF; Lopes, Natália P NP; Malta, Frederico S V FSV; Freire, Maíra C M MCM

Publication Date: 2021-02-25

Variant appearance in text: EGFR: G719N

PubMed Link: 33632153

Variant Present in the following documents:

• Main text
• 12885_2021_Article_7884.pdf

View BVdb publication page

---

Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment.

Cancer Research And Treatment

Tseng, Jeng-Sen JS; Yang, Tsung-Ying TY; Chen, Kun-Chieh KC; Hsu, Kuo-Hsuan KH; Huang, Yen-Hsiang YH; Su, Kang-Yi KY; Yu, Sung-Liang SL; Chang, Gee-Chen GC

Publication Date: 2018-10

Variant appearance in text: EGFR: G719N

PubMed Link: 29228521

Variant Present in the following documents:

• crt-2017-460-suppl1.pdf

View BVdb publication page

---

The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.

Oncotarget

Tseng, Jeng-Sen JS; Su, Kang-Yi KY; Yang, Tsung-Ying TY; Chen, Kun-Chieh KC; Hsu, Kuo-Hsuan KH; Chen, Hsuan-Yu HY; Tsai, Chi-Ren CR; Yu, Sung-Liang SL; Chang, Gee-Chen GC

Publication Date: 2016-07-26

Variant appearance in text: EGFR: G719N

PubMed Link: 27384480

Variant Present in the following documents:

• oncotarget-07-48059-s001.pdf

View BVdb publication page

---

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan.

Plos One

Hsu, Kuo-Hsuan KH; Ho, Chao-Chi CC; Hsia, Te-Chun TC; Tseng, Jeng-Sen JS; Su, Kang-Yi KY; Wu, Ming-Fang MF; Chiu, Kuo-Liang KL; Yang, Tsung-Ying TY; Chen, Kun-Chieh KC; Ooi, Hean H; Wu, Tzu-Chin TC; Chen, Hung-Jen HJ; Chen, Hsuan-Yu HY; Chang, Chi-Sheng CS; Hsu, Chung-Ping CP; Hsia, Jiun-Yi JY; Chuang, Cheng-Yen CY; Lin, Chin-Hung CH; Chen, Jeremy J W JJ; Chen, Kuan-Yu KY; Liao, Wei-Yu WY; Shih, Jin-Yuan JY; Yu, Sung-Liang SL; Yu, Chong-Jen CJ; Yang, Pan-Chyr PC; Chang, Gee-Chen GC

Publication Date: 2015

Variant appearance in text: EGFR: G719N

PubMed Link: 25789627

Variant Present in the following documents:

• Main text
• pone.0120852.pdf

View BVdb publication page

---

Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.

Plos One

Tseng, Jeng-Sen JS; Wang, Chih-Liang CL; Huang, Ming-Shyan MS; Chen, Chung-Yu CY; Chang, Cheng-Yu CY; Yang, Tsung-Ying TY; Tsai, Chi-Ren CR; Chen, Kun-Chieh KC; Hsu, Kuo-Hsuan KH; Tsai, Meen-Hsin MH; Yu, Sung-Liang SL; Su, Kang-Yi KY; Wu, Chih-Wei CW; Yang, Cheng-Ta CT; Chen, Yuh-Min YM; Chang, Gee-Chen GC

Publication Date: 2014

Variant appearance in text: EGFR: G719N

PubMed Link: 25215536

Variant Present in the following documents:

• pone.0107160.s001.pdf

View BVdb publication page

---